Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gynecology

  Free Subscription

Articles published in
Cancer
    October 2021
  1. NIERENGARTEN MB
    Study shows a decrease in cervical cancer but a rise in other human papillomavirus-related cancers.
    Cancer. 2021;127:3499.
    >> Share

    August 2021
  2. LIN S, Gao K, Gu S, You L, et al
    Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years.
    Cancer. 2021 Aug 9. doi: 10.1002/cncr.33795.
    >> Share

  3. HUEPENBECKER SP, Sun CC, Fu S, Zhao H, et al
    Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States.
    Cancer. 2021 Aug 4. doi: 10.1002/cncr.33829.
    >> Share

    July 2021
  4. LEHRER S, Rheinstein PH
    FBXW7, L1CAM, and TGM2 in endometrial cancer.
    Cancer. 2021 Jul 29. doi: 10.1002/cncr.33782.
    >> Share

  5. URICK ME, Yu EJ, Bell DW
    Reply to FBXW7, L1CAM, and TGM2 in endometrial cancer.
    Cancer. 2021 Jul 29. doi: 10.1002/cncr.33781.
    >> Share

  6. LAMOTHE S, Ramia de Cap M
    Survival analysis and treatment effects in patients with endometrial cancer and POLE mutations.
    Cancer. 2021 Jul 27. doi: 10.1002/cncr.33806.
    >> Share

  7. TALHOUK A, McAlpine JN
    Reply to Survival analysis and treatment effects in patients with endometrial cancer and POLE mutations.
    Cancer. 2021 Jul 27. doi: 10.1002/cncr.33808.
    >> Share

  8. MIX JM, Saraiya M, Thompson TD, Querec TD, et al
    Prevalence of human papillomavirus genotypes in high-grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States.
    Cancer. 2021 Jul 21. doi: 10.1002/cncr.33582.
    >> Share

  9. NYAKUDARIKA NC, Holschneider CH, Sinno AK
    Universal social needs assessment in gynecologic oncology: An important step toward more informed and targeted care in the public safety net.
    Cancer. 2021 Jul 12. doi: 10.1002/cncr.33761.
    >> Share

    June 2021
  10. PRINTZ C
    Some patients with postmenopausal breast cancer can avoid adjuvant chemotherapy: Data indicate that some postmenopausal women with breast cancer can safely skip adjuvant chemotherapy.
    Cancer. 2021;127:1951-1952.
    >> Share

    May 2021
  11. KIM SR, Tone A, Kim RH, Cesari M, et al
    Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer.
    Cancer. 2021 May 13. doi: 10.1002/cncr.33625.
    >> Share

  12. GARCIA-SOTO AE, McKenzie ND, Whicker ME, Pearson JM, et al
    Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer.
    Cancer. 2021 May 1. doi: 10.1002/cncr.33449.
    >> Share

    April 2021
  13. BUTLER SS, Mahal BA, Moslehi JJ, Nohria A, et al
    Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Controlled Trial.
    Cancer. 2021 Apr 27. doi: 10.1002/cncr.33486.
    >> Share

  14. CHEN YS, Zhou ZN, Glynn SM, Frey MK, et al
    Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the coronavirus disease 2019 (COVID-19) pandemic among low-income women in New York City.
    Cancer. 2021 Apr 26. doi: 10.1002/cncr.33537.
    >> Share

  15. URICK ME, Yu EJ, Bell DW
    High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels.
    Cancer. 2021 Apr 19. doi: 10.1002/cncr.33567.
    >> Share

  16. PRINTZ C
    Lower Cervical Cancer Risk Associated With HPV Vaccine.
    Cancer. 2021;127:1171.
    >> Share

  17. TAIT SD, Ren Y, Horton CC, Oshima SM, et al
    Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.
    Cancer. 2021 Apr 7. doi: 10.1002/cncr.33473.
    >> Share

  18. MCALPINE JN, Chiu DS, Nout RA, Church DN, et al
    Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis.
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33516.
    >> Share

    March 2021
  19. LEE CK, Friedlander ML, Tjokrowidjaja A, Ledermann JA, et al
    Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis.
    Cancer. 2021 Mar 19. doi: 10.1002/cncr.33517.
    >> Share

  20. RODRIGUEZ VE, LeBron AMW, Chang J, Bristow RE, et al
    Guideline-adherent treatment, sociodemographic disparities, and cause-specific survival for endometrial carcinomas.
    Cancer. 2021 Mar 15. doi: 10.1002/cncr.33502.
    >> Share

    February 2021
  21. MULLINS MA, Ruterbusch JJ, Clarke P, Uppal S, et al
    Trends and racial disparities in aggressive end-of-life care for a national sample of women with ovarian cancer.
    Cancer. 2021 Feb 25. doi: 10.1002/cncr.33488.
    >> Share

  22. MUKAMA T, Kharazmi E, Sundquist K, Sundquist J, et al
    Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study.
    Cancer. 2021 Feb 23. doi: 10.1002/cncr.33456.
    >> Share

    January 2021
  23. SELLA T, Partridge AH
    A new look at old problems: Ovarian function suppression in the real world.
    Cancer. 2021 Jan 28. doi: 10.1002/cncr.33368.
    >> Share

  24. REEDER-HAYES KE, Mayer SE, Lund JL
    Adherence to endocrine therapy including ovarian suppression: A large observational cohort study of US women with early breast cancer.
    Cancer. 2021 Jan 28. doi: 10.1002/cncr.33367.
    >> Share

  25. MELIN JM, Seppanen VI, Ylostalo TM, Malila NK, et al
    Risk of induced abortions in childhood cancer survivors.
    Cancer. 2021 Jan 25. doi: 10.1002/cncr.33384.
    >> Share

  26. YUAN Y, Pan K, Mortimer J, Chlebowski RT, et al
    Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative.
    Cancer. 2021 Jan 21. doi: 10.1002/cncr.33407.
    >> Share

    December 2020
  27. LARA OD, Smith MJ, Wang Y, O'Cearbhaill R, et al
    Racial disparities in patients with coronavirus disease 2019 infection and gynecologic malignancy.
    Cancer. 2020 Dec 9. doi: 10.1002/cncr.33335.
    >> Share

  28. PRINTZ C
    Screening entire populations for breast and ovarian cancer could prevent millions of cases worldwide, study says.
    Cancer. 2020;126:5007.
    >> Share

  29. POORVU PD, Gelber SI, Zheng Y, Ruddy KJ, et al
    Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer.
    Cancer. 2020 Dec 1. doi: 10.1002/cncr.33342.
    >> Share

    September 2020
  30. GHIRARDI V, Ronsini C, Trozzi R, Di Ilio C, et al
    Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience.
    Cancer. 2020 Sep 15. doi: 10.1002/cncr.33167.
    >> Share

  31. DUSKA LR, Scalici JM, Temkin SM, Schwarz JK, et al
    Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer.
    Cancer. 2020 Sep 10. doi: 10.1002/cncr.33136.
    >> Share

  32. DESSOURCES K, Hari A, Pineda E, Amneus MW, et al
    Socially determined cervical cancer care navigation: An effective step toward health care equity and care optimization.
    Cancer. 2020 Sep 5. doi: 10.1002/cncr.33124.
    >> Share

    August 2020
  33. KIM SR, Tone A, Kim RH, Cesari M, et al
    Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer.
    Cancer. 2020 Aug 18. doi: 10.1002/cncr.33144.
    >> Share

  34. GATTI A, Haruyama R, Elit L, Howard SC, et al
    How to reduce the impact of cervical cancer worldwide: Gaps and priority areas identified through the essential cancer and primary care packages: An analysis of effective interventions.
    Cancer. 2020 Aug 11. doi: 10.1002/cncr.33116.
    >> Share

  35. KIM EY, Chang Y, Ahn J, Yun JS, et al
    Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women.
    Cancer. 2020 Aug 7. doi: 10.1002/cncr.33138.
    >> Share

  36. PRINTZ C
    Experts say that cervical cancer could be eliminated worldwide with screening, human papillomavirus vaccine.
    Cancer. 2020;126:3387.
    >> Share

    July 2020
  37. LARA OD, O'Cearbhaill RE, Smith MJ, Sutter ME, et al
    COVID-19 outcomes of patients with gynecologic cancer in New York City.
    Cancer. 2020 Jul 30. doi: 10.1002/cncr.33084.
    >> Share

  38. CORR BR, Moroney M, Sheeder J, Eckhardt SG, et al
    Survival and clinical outcomes of patients with ovarian cancer who were treated on phase 1 clinical trials.
    Cancer. 2020 Jul 22. doi: 10.1002/cncr.33073.
    >> Share

  39. LUTGENDORF SK, Penedo F, Goodheart MJ, Dahmoush L, et al
    Epithelial-mesenchymal transition polarization in ovarian carcinomas from patients with high social isolation.
    Cancer. 2020 Jul 21. doi: 10.1002/cncr.33060.
    >> Share

  40. SRIVASTAVA AJ, Contreras JA, Davis M, Markovina ST, et al
    Early posttherapy clearance of human papillomavirus and treatment response in cervical carcinoma.
    Cancer. 2020 Jul 8. doi: 10.1002/cncr.33040.
    >> Share

    June 2020
  41. PAN K, Chlebowski RT, Mortimer JE, Gunther MJ, et al
    Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative.
    Cancer. 2020 Jun 12. doi: 10.1002/cncr.33002.
    >> Share

  42. BLESSING AM, Santiago-O'Farrill JM, Mao W, Pang L, et al
    Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition.
    Cancer. 2020 Jun 2. doi: 10.1002/cncr.32985.
    >> Share

  43. WESTRICK AC, Bailey ZD, Schlumbrecht M, Hlaing WM, et al
    Residential segregation and overall survival of women with epithelial ovarian cancer.
    Cancer. 2020 Jun 2. doi: 10.1002/cncr.32989.
    >> Share

    May 2020
  44. POORT H, de Rooij BH, Uno H, Weng S, et al
    Patterns and predictors of cancer-related fatigue in ovarian and endometrial cancers: 1-year longitudinal study.
    Cancer. 2020 May 21. doi: 10.1002/cncr.32927.
    >> Share

  45. PRINTZ C
    Research teams unite to develop an early detection test for ovarian cancer.
    Cancer. 2020;126:2113.
    >> Share

    April 2020
  46. RODRIGUEZ AM, Zeybek B, Vaughn M, Westra J, et al
    Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study.
    Cancer. 2020;126:1656-1667.
    >> Share


  47. The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms.
    Cancer. 2020 Apr 13. doi: 10.1002/cncr.32867.
    >> Share

    March 2020
  48. CHLEBOWSKI RT, Aragaki AK, Anderson GL, Prentice RL, et al
    Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women.
    Cancer. 2020 Mar 25. doi: 10.1002/cncr.32846.
    >> Share

  49. RUSSO M, Newell JM, Budurlean L, Houser KR, et al
    Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma.
    Cancer. 2020 Mar 18. doi: 10.1002/cncr.32822.
    >> Share

  50. SALCEDO MP, Sood AK, Jhingran A, Eifel PJ, et al
    Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women.
    Cancer. 2020 Mar 3. doi: 10.1002/cncr.32807.
    >> Share

    February 2020
  51. LEE YC, Wang L, Kohn EC, Rubinstein L, et al
    Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancer.
    Cancer. 2020 Feb 25. doi: 10.1002/cncr.32783.
    >> Share

  52. PETERSON LL, Park S, Park Y, Colditz GA, et al
    Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study.
    Cancer. 2020 Feb 25. doi: 10.1002/cncr.32798.
    >> Share

  53. PRINTZ C
    Study finds that women with posttraumatic stress disorder have an increased risk of ovarian cancer.
    Cancer. 2020;126:468-469.
    >> Share

  54. PRINTZ C
    Low-income, Asian American women benefit from human papillomavirus self-sampling tests.
    Cancer. 2020;126:469.
    >> Share

  55. VYSOTSKAIA V, Kaseniit KE, Bucheit L, Ready K, et al
    Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.
    Cancer. 2020;126:549-558.
    >> Share

    January 2020
  56. KROENKE CH, Paskett ED, Cene CW, Caan BJ, et al
    Prediagnosis social support, social integration, living status, and colorectal cancer mortality in postmenopausal women from the women's health initiative.
    Cancer. 2020 Jan 23. doi: 10.1002/cncr.32710.
    >> Share

  57. PRINTZ C
    Psychological stress is associated with a higher risk of cervical cancer mortality.
    Cancer. 2020;126:240-241.
    >> Share

  58. GUO F, Scholl M, Fuchs EL, Berenson AB, et al
    BRCA testing in unaffected young women in the United States, 2006-2017.
    Cancer. 2020;126:337-343.
    >> Share

    December 2019
  59. RUBINSTEIN MM, Hyman DM, Caird I, Won H, et al
    Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway.
    Cancer. 2019 Dec 27. doi: 10.1002/cncr.32677.
    >> Share

  60. VERGOTE I, Harter P, Chiva L
    Hyperthermic intraperitoneal chemotherapy does not improve survival in advanced ovarian cancer.
    Cancer. 2019;125 Suppl 24:4594-4597.
    >> Share

  61. BOOKMAN MA
    Can we predict who lives long with ovarian cancer?
    Cancer. 2019;125 Suppl 24:4578-4581.
    >> Share

  62. AREND R, Martinez A, Szul T, Birrer MJ, et al
    Biomarkers in ovarian cancer: To be or not to be.
    Cancer. 2019;125 Suppl 24:4563-4572.
    >> Share

  63. LEE JM, Minasian L, Kohn EC
    New strategies in ovarian cancer treatment.
    Cancer. 2019;125 Suppl 24:4623-4629.
    >> Share

  64. SEHOULI J, Grabowski JP
    Surgery in recurrent ovarian cancer.
    Cancer. 2019;125 Suppl 24:4598-4601.
    >> Share

  65. PIGNATA S, Pisano C, Di Napoli M, Cecere SC, et al
    Treatment of recurrent epithelial ovarian cancer.
    Cancer. 2019;125 Suppl 24:4609-4615.
    >> Share

  66. FUJIWARA K, Hasegawa K, Nagao S
    Landscape of systemic therapy for ovarian cancer in 2019: Primary therapy.
    Cancer. 2019;125 Suppl 24:4582-4586.
    >> Share

  67. KOOLE SN, van Driel WJ, Sonke GS
    Hyperthermic intraperitoneal chemotherapy for ovarian cancer: The heat is on.
    Cancer. 2019;125 Suppl 24:4587-4593.
    >> Share

  68. FRIEDLANDER ML
    Do all patients with recurrent ovarian cancer need systemic therapy?
    Cancer. 2019;125 Suppl 24:4602-4608.
    >> Share

  69. GONZALEZ-MARTIN A, Sanchez-Lorenzo L
    Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: Still promising?
    Cancer. 2019;125 Suppl 24:4616-4622.
    >> Share

  70. HARTER P, Heitz F, Ataseven B, Schneider S, et al
    How to manage lymph nodes in ovarian cancer.
    Cancer. 2019;125 Suppl 24:4573-4577.
    >> Share

    November 2019
  71. CRAFTON SM, Cohn DE, Llamocca EN, Louden E, et al
    Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries.
    Cancer. 2019 Nov 27. doi: 10.1002/cncr.32620.
    >> Share

  72. YANG WL, Lu Z, Guo J, Fellman BM, et al
    Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer.
    Cancer. 2019 Nov 12. doi: 10.1002/cncr.32582.
    >> Share

  73. SANTIAGO-O'FARRILL JM, Weroha SJ, Hou X, Oberg AL, et al
    Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models.
    Cancer. 2019 Nov 12. doi: 10.1002/cncr.32600.
    >> Share

  74. HUNG P, Deng S, Zahnd WE, Adams SA, et al
    Geographic disparities in residential proximity to colorectal and cervical cancer care providers.
    Cancer. 2019 Nov 8. doi: 10.1002/cncr.32594.
    >> Share

  75. PRINTZ C
    Survey of US gynecologic oncologists finds that approximately 64% have experienced sexual harassment.
    Cancer. 2019;125:3691.
    >> Share

    October 2019
  76. PRINTZ C
    Rethinking a common surgery technique for early cervical cancer: Experts are reconsidering the use of minimally invasive radical hysterectomy as a treatment for early cervical cancer after multiple studies found that patients who undergo the procedure
    Cancer. 2019;125:3485-3487.
    >> Share

  77. PRINTZ C
    Cervical cancer subtype less detectable by Papanicolaou testing.
    Cancer. 2019;125:3287.
    >> Share

    September 2019
  78. FICHT AL, Lapidos-Salaiz I, Phelps BR
    Eliminating cervical cancer: Promising developments in primary prevention.
    Cancer. 2019 Sep 26. doi: 10.1002/cncr.32507.
    >> Share

    August 2019
  79. HAVRILESKY LJ, Yang JC, Lee PS, Secord AA, et al
    Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer.
    Cancer. 2019 Aug 27. doi: 10.1002/cncr.32447.
    >> Share

  80. MULLINS MA, Peres LC, Alberg AJ, Bandera EV, et al
    Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study.
    Cancer. 2019 Aug 15. doi: 10.1002/cncr.32451.
    >> Share

    July 2019
  81. PRINTZ C
    HPV infections most often linked to cervical cancer have declined.
    Cancer. 2019;125:2336-2337.
    >> Share

    June 2019
  82. STEWART KI, Chasen B, Erwin W, Fleming N, et al
    Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.
    Cancer. 2019 Jun 21. doi: 10.1002/cncr.32329.
    >> Share

  83. HOLLIS RL, Churchman M, Michie CO, Rye T, et al
    High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum.
    Cancer. 2019 Jun 2. doi: 10.1002/cncr.32079.
    >> Share

  84. KONDRASHOVA O, Scott CL
    Clarifying the role of EMSY in DNA repair in ovarian cancer.
    Cancer. 2019 Jun 2. doi: 10.1002/cncr.32135.
    >> Share

    May 2019
  85. KAHN RM, Gordhandas S, Maddy BP, Baltich Nelson B, et al
    Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
    Cancer. 2019 May 31. doi: 10.1002/cncr.32203.
    >> Share

  86. WASSERMANN J, Gelber SI, Rosenberg SM, Ruddy KJ, et al
    Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer.
    Cancer. 2019 May 23. doi: 10.1002/cncr.32192.
    >> Share

  87. PRINTZ C
    Cervical cancer self-sampling tests could improve access.
    Cancer. 2019;125:1583.
    >> Share

  88. PRINTZ C
    Culturally tailored intervention increases HPV vaccination rates among Asian American adolescents.
    Cancer. 2019;125:1583.
    >> Share

  89. PINSKY PF, Black A, Daugherty SE, Hoover R, et al
    Metastatic prostate cancer at diagnosis and through progression in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Cancer. 2019 May 8. doi: 10.1002/cncr.32176.
    >> Share

    April 2019
  90. TSUI J, DeLia D, Stroup AM, Nova J, et al
    Association of Medicaid enrollee characteristics and primary care utilization with cancer outcomes for the period spanning Medicaid expansion in New Jersey.
    Cancer. 2019;125:1330-1340.
    >> Share

  91. LI K, Li Q, Song L, Wang D, et al
    The distribution and prevalence of human papillomavirus in women in mainland China.
    Cancer. 2019;125:1030-1037.
    >> Share

    March 2019
  92. KURNIT KC, Westin SN, Coleman RL
    Microsatellite instability in endometrial cancer: New purpose for an old test.
    Cancer. 2019 Mar 26. doi: 10.1002/cncr.32058.
    >> Share

  93. BAST RC JR, Matulonis UA, Sood AK, Ahmed AA, et al
    Critical Questions in Ovarian Cancer Research and Treatment: Report of an American Association for Cancer Research Special Conference.
    Cancer. 2019 Mar 5. doi: 10.1002/cncr.32004.
    >> Share

  94. DE ROOIJ BH, Ezendam NPM, Vos MC, Pijnenborg JMA, et al
    Patients' information coping styles influence the benefit of a survivorship care plan in the ROGY Care Trial: New insights for tailored delivery.
    Cancer. 2019;125:788-797.
    >> Share

    February 2019
  95. GROVER S, MacDuffie EC, Wang Q, Bvochora-Nsingo M, et al
    HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana.
    Cancer. 2019 Feb 25. doi: 10.1002/cncr.31972.
    >> Share

  96. LITTLE RF
    Tearing down the false walls to HIV cancer care.
    Cancer. 2019 Feb 25. doi: 10.1002/cncr.31974.
    >> Share

    January 2019
  97. FROBERG M, Ostensson E, Belkic K, Ostrbenk A, et al
    Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
    Cancer. 2019;125:239-248.
    >> Share

  98. DING DC, Chen W, Wang JH, Lin SZ, et al
    Thyroid cancer risk in women with infertility and association with fertility medications in Taiwan.
    Cancer. 2019 Jan 15. doi: 10.1002/cncr.31964.
    >> Share

  99. MAO W, Peters HL, Sutton MN, Orozco AF, et al
    The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts.
    Cancer. 2019 Jan 8. doi: 10.1002/cncr.31935.
    >> Share

    December 2018
  100. TEMKIN SM, Mallen A, Bellavance E, Rubinsak L, et al
    The role of menopausal hormone therapy in women with or at risk of ovarian and breast cancers: Misconceptions and current directions.
    Cancer. 2018 Dec 20. doi: 10.1002/cncr.31911.
    >> Share

  101. ESKANDER RN
    Mismatch repair in endometrioid endometrial cancer: Increasing our therapeutic proficiency by capitalizing on molecular deficiency.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31902.
    >> Share

  102. BACKES FJ, Haag J, Cosgrove CM, Suarez A, et al
    Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31901.
    >> Share

  103. PRINTZ C
    High-risk human papillomavirus test a good option for cervical cancer screening.
    Cancer. 2018;124:4591.
    >> Share

  104. PRINTZ C
    Human papillomavirus testing may detect cervical precancer better than Papanicolaou testing.
    Cancer. 2018;124:4430-4431.
    >> Share

    November 2018
  105. BINES J, Tevaarwerk AJ
    Baby steps: Pregnancy outcomes after human epidermal growth factor receptor 2-targeted therapy.
    Cancer. 2018 Nov 30. doi: 10.1002/cncr.31878.
    >> Share

  106. LAITMAN Y, Michaelson-Cohen R, Levi E, Chen-Shtoyerman R, et al
    Uterine cancer in Jewish Israeli BRCA1/BRCA2 mutation carriers.
    Cancer. 2018 Nov 29. doi: 10.1002/cncr.31842.
    >> Share

  107. FREY MK, Kopparam RV, Ni Zhou Z, Fields JC, et al
    Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
    Cancer. 2018 Nov 27. doi: 10.1002/cncr.31856.
    >> Share

  108. AHVENAINEN TV, Makinen NM, von Nandelstadh P, Vahteristo MEA, et al
    Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.
    Cancer. 2018 Nov 13. doi: 10.1002/cncr.31754.
    >> Share

  109. SMITH HJ, McCaw TR, Londono AI, Katre AA, et al
    The antitumor effects of entinostat in ovarian cancer require adaptive immunity.
    Cancer. 2018 Nov 13. doi: 10.1002/cncr.31761.
    >> Share

  110. HARTNETT KP, Mertens AC, Kramer MR, Lash TL, et al
    Pregnancy after cancer: Does timing of conception affect infant health?
    Cancer. 2018 Nov 7. doi: 10.1002/cncr.31732.
    >> Share

  111. PARTRIDGE AH
    Pregnancy after cancer: Timing is everything.
    Cancer. 2018 Nov 7. doi: 10.1002/cncr.31730.
    >> Share

  112. MAILHOT VEGA RB, Balogun OD, Ishaq OF, Bray F, et al
    Estimating child mortality associated with maternal mortality from breast and cervical cancer.
    Cancer. 2018 Nov 1. doi: 10.1002/cncr.31780.
    >> Share

    October 2018
  113. ORTIZ AP, Engels EA, Nogueras-Gonzalez GM, Colon-Lopez V, et al
    Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected hispanics living in the United States.
    Cancer. 2018 Oct 22. doi: 10.1002/cncr.31702.
    >> Share

  114. LAMBERTINI M, Martel S, Campbell C, Guillaume S, et al
    Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.
    Cancer. 2018 Oct 18. doi: 10.1002/cncr.31784.
    >> Share

  115. HOSKINS KF, Tejeda S, Vijayasiri G, Chukwudozie IB, et al
    A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.
    Cancer. 2018 Oct 15. doi: 10.1002/cncr.31635.
    >> Share

  116. CHLEBOWSKI RT, Luo J, Anderson GL, Barrington W, et al
    Weight loss and breast cancer incidence in postmenopausal women.
    Cancer. 2018 Oct 8. doi: 10.1002/cncr.31687.
    >> Share

    September 2018

  117. Survivors of endometrial cancer are more likely to experience cardiovascular problems.
    Cancer. 2018;124:3633.
    >> Share

    June 2018
  118. ARMER JS, Clevenger L, Davis LZ, Cuneo M, et al
    Life stress as a risk factor for sustained anxiety and cortisol dysregulation during the first year of survivorship in ovarian cancer.
    Cancer. 2018 Jun 15. doi: 10.1002/cncr.31570.
    >> Share

    May 2018
  119. DUSKA LR
    Access to quality gynecologic oncology care: A work in progress.
    Cancer. 2018 May 16. doi: 10.1002/cncr.31391.
    >> Share

  120. SHALOWITZ DI, Huh WK
    Access to gynecologic oncology care and the network adequacy standard.
    Cancer. 2018 May 16. doi: 10.1002/cncr.31392.
    >> Share

  121. ADAR T, Rodgers LH, Shannon KM, Yoshida M, et al
    Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.
    Cancer. 2018 May 11. doi: 10.1002/cncr.31534.
    >> Share

    March 2018

  122. Erratum: Pashankar F, Hale JP, Dang H, et al. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative. Cancer. 2016;122:230-237.
    Cancer. 2018;124:1302.
    >> Share

  123. EL-JAWAHRI A, Fishman SR, Vanderklish J, Dizon DS, et al
    Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation.
    Cancer. 2018 Mar 14. doi: 10.1002/cncr.31333.
    >> Share

    February 2018
  124. IYER NS, Cartmel B, Friedman L, Li F, et al
    Lymphedema in ovarian cancer survivors: Assessing diagnostic methods and the effects of physical activity.
    Cancer. 2018 Feb 13. doi: 10.1002/cncr.31239.
    >> Share

  125. PRINTZ C
    Abdominal fat linked to cancer risk in postmenopausal women.
    Cancer. 2018;124:449.
    >> Share

    January 2018
  126. LEVINE JM, Whitton JA, Ginsberg JP, Green DM, et al
    Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31121.
    >> Share

  127. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    >> Share

    December 2017
  128. STEWART SL, Harewood R, Matz M, Rim SH, et al
    Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5138-5159.
    >> Share

  129. BENARD VB, Watson M, Saraiya M, Harewood R, et al
    Cervical cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5119-5137.
    >> Share

  130. PRINTZ C
    Women who undergo HPV testing receive earlier detection and treatment of cervical precancers.
    Cancer. 2017;123:4751.
    >> Share

  131. TAARNHOJ GA, Christensen IJ, Lajer H, Fuglsang K, et al
    Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study.
    Cancer. 2017 Dec 6. doi: 10.1002/cncr.31165.
    >> Share

  132. GROEN R, Abe K, Yoon HS, Li Z, et al
    Application of microscope-based scanning software (Panoptiq) for the interpretation of cervicovaginal cytology specimens.
    Cancer. 2017;125:918-925.
    >> Share

    November 2017
  133. PRINTZ C
    Large population study quantifies chances of pregnancy after cancer treatment.
    Cancer. 2017;123:4308.
    >> Share

  134. LUTGENDORF SK, Thaker PH, Arevalo JM, Goodheart MJ, et al
    Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31078.
    >> Share

    October 2017
  135. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
    Psychological distress associated with cancer screening: A systematic review.
    Cancer. 2017;123:3882-3894.
    >> Share

  136. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    >> Share

    September 2017
  137. LE GALLO M, Rudd ML, Urick ME, Hansen NF, et al
    The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.
    Cancer. 2017 Sep 21. doi: 10.1002/cncr.30971.
    >> Share

  138. PRINJA S, Bahuguna P, Faujdar DS, Jyani G, et al
    Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program.
    Cancer. 2017;123:3253-3260.
    >> Share

    August 2017
  139. TRACHT JM, Davis AD, Fasciano DN, Eltoum IA, et al
    Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?
    Cancer. 2017 Aug 17. doi: 10.1002/cncy.21905.
    >> Share

  140. MOORE KN, Borghaei H, O'Malley DM, Jeong W, et al
    Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor alpha-targeting antibody-drug conjugate, in patients with solid tumors.
    Cancer. 2017;123:3080-3087.
    >> Share

  141. HUNG YP, Lovitch SB, Qian X
    Histiocytic sarcoma: New insights into FNA cytomorphology and molecular characteristics.
    Cancer. 2017;125:604-614.
    >> Share

    July 2017
  142. PRINTZ C
    Expert panel issues new global cervical cancer screening guideline.
    Cancer. 2017;123:2387-2388.
    >> Share

    June 2017
  143. GE Y, Christensen P, Luna E, Armylagos D, et al
    Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
    Cancer. 2017 Jun 2. doi: 10.1002/cncy.21875.
    >> Share

    May 2017
  144. GUO M, Khanna A, Wang J, Dawlett MA, et al
    Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Cancer. 2017 May 12. doi: 10.1002/cncy.21877.
    >> Share

  145. IVY SP, Kohn EC
    Drug development and registration: Challenges and opportunities in ovarian cancer.
    Cancer. 2017 May 12. doi: 10.1002/cncr.30645.
    >> Share

    March 2017
  146. SAMIMI G, Minasian LM
    Opportunistic salpingectomy: What about the role of the ovary in ovarian cancer?
    Cancer. 2017 Mar 23. doi: 10.1002/cncr.30525.
    >> Share

    February 2017
  147. ZANET E, Ciancia R, Michieli M, Tirelli U, et al
    "Twistin' the night away": Fertility preservation in young adult female cancer survivors.
    Cancer. 2017;123:707-708.
    >> Share

  148. BENEDICT C, Thom B, Friedman DN, Diotallevi D, et al
    Reply to "Twistin' the night away": Fertility preservation in young adult female cancer survivors.
    Cancer. 2017;123:708-709.
    >> Share

  149. JACKSON SE, Steptoe A, Fisher A
    Reply to Sexual quality of life in the cancer continuum.
    Cancer. 2017;123:530-531.
    >> Share

    December 2016
  150. GULATI R, Albertsen PC
    Insights from the PLCO trial about prostate cancer screening.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30472.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016